Senti Biosciences
SNTI
SNTI
16 hedge funds and large institutions have $3.23M invested in Senti Biosciences in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$181K | |
| 2 | +$47K | |
| 3 | +$35.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$29.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$706 |
Top Sellers
| 1 | -$612K | |
| 2 | -$109K | |
| 3 | -$4.69K | |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$3.39K |
| 5 |
Morgan Stanley
New York
|
-$1.43K |